Drugs / ICG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05517681 | Sep 2020 → Jul 2022 | — | The First Hospital of Qinhuangdao | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ICG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05517681 ↗ |
| Modality | Diagnostic / imaging agent | “Indocyanine green NIR imaging is valuable for lymph node dissection in D3 radical surgery for rectal cancer.” NCT05517681 ↗ |
| Route | Other | “ICG was injected preoperatively via anoscope or anal dilator in the mucosal layer around the tumor” NCT05517681 ↗ |